Home > Boards > Canadian > Biotechs > Vanc Pharmaceuticals Inc. (TSXV:NPH)

Alda Pharmaceuticals director McCoy resigns

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
woodstock135 Member Profile
 
Followed By 2
Posts 243
Boards Moderated 0
Alias Born 05/21/08
160x600 placeholder
woodstock135   Friday, 12/07/12 02:48:47 PM
Re: None
Post # of 4094 
Alda Pharmaceuticals director McCoy resigns

2012-12-05 16:12 ET - News Release


Dr. Terrance Owen reports

DR. MCCOY RESIGNS AS A DIRECTOR AND JOINS ALDA'S ADVISORY BOARD

Alda Pharmaceuticals Corp. director Dr. William McCoy has resigned, effective Nov. 28, 2012, and has joined the company's advisory board.

In 2005, Dr. McCoy became a director of Alda and chief technology officer of Phigenics LLC, a life sciences technology company based in Chicago, Ill. In 2001, he received the Intellectual Property Law Association inventor of the year award, and a medal for outstanding contribution to management and science from the International Water Association in Berlin. He has served the American Society of Heating, Refrigerating and Air-conditioning Engineers (ASHRAE) as chair of the environmental health committee, and is presently chair of the committee developing a new standard: preventing legionellosis associated with building water systems. Dr. McCoy authored a full-length book, "Preventing Legionellosis," in 2006, and holds 29 patents in diagnostics, control and manufacturing of anti-microbials. Dr. McCoy's expertise in infection control will be an important asset to the company as it continues the development of its T36 technology.

The company wishes to thank Dr. McCoy for his service as a director and welcomes him to the advisory board. He joins Dr. Brian Conway, who is an internationally recognized researcher in the field of infectious diseases. The company is expecting to appoint additional equally qualified individuals to its advisory board to reflect its focus on the acquisition of the global marketing and sales rights to novel generic, over-the-counter and natural pharmaceutical products.

The company currently has a vacancy on its board of directors and is seeking a qualified person who can contribute to this new international pharmaceutical marketing effort.

We seek Safe Harbor.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist